Suluck Soontaros1, Nattawut Leelakanok2. 1. Department of Pharmacy Unit, Chonburi Hospital, Chonburi, Thailand; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand. Electronic address: sulucksoontaros@gmail.com. 2. Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand.
Abstract
BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) has emerged in health care facilities around the world. Several studies demonstrated data regarding clinical outcomes for CRE infections including death. This systematic review and meta-analysis summarized literature discussing association between CRE and mortality. METHODS: A systematic literature review was performed by searching EMBASE, International Pharmaceutical Abstract databases, PubMed, and Scopus and to identify studies that assessed the association between CRE and death published from April 2012 to October 2017. A meta-analysis was performed using a random effect model. Heterogeneity was assessed using the I2-statistic. RESULTS: Twenty-one studies were included in this meta-analysis. The underlying populations were moderately heterogeneous (I2 = 60%; P = .01). Pooled risk estimates from 9 studies revealed a significant association between CRE and death (pooled-adjusted odds ratio: 2.85; 95% confidence interval: 1.88, 4.30). The unadjusted variable pooled from 18 studies demonstrated a significant association between CRE and death (pooled-unadjusted odds ratio: 3.73; 95% confidence interval: 2.02, 6.88). DISCUSSION: The finding that CRE infection was positively associated with death agreed with the previous meta-analysis of studies published before April 2012. CONCLUSIONS: This meta-analysis found that CRE was associated with increased risk of death. Our analysis implies a need for strict infection control measures.
BACKGROUND:Carbapenem-resistant Enterobacteriaceae (CRE) has emerged in health care facilities around the world. Several studies demonstrated data regarding clinical outcomes for CRE infections including death. This systematic review and meta-analysis summarized literature discussing association between CRE and mortality. METHODS: A systematic literature review was performed by searching EMBASE, International Pharmaceutical Abstract databases, PubMed, and Scopus and to identify studies that assessed the association between CRE and death published from April 2012 to October 2017. A meta-analysis was performed using a random effect model. Heterogeneity was assessed using the I2-statistic. RESULTS: Twenty-one studies were included in this meta-analysis. The underlying populations were moderately heterogeneous (I2 = 60%; P = .01). Pooled risk estimates from 9 studies revealed a significant association between CRE and death (pooled-adjusted odds ratio: 2.85; 95% confidence interval: 1.88, 4.30). The unadjusted variable pooled from 18 studies demonstrated a significant association between CRE and death (pooled-unadjusted odds ratio: 3.73; 95% confidence interval: 2.02, 6.88). DISCUSSION: The finding that CRE infection was positively associated with death agreed with the previous meta-analysis of studies published before April 2012. CONCLUSIONS: This meta-analysis found that CRE was associated with increased risk of death. Our analysis implies a need for strict infection control measures.
Authors: Maísa Soares de Oliveira; João Augusto Oshiro-Junior; Mariana Rillo Sato; Marta Maria Conceição; Ana Cláudia Dantas Medeiros Journal: Pharmaceutics Date: 2020-07-23 Impact factor: 6.321
Authors: Astrid V Cienfuegos-Gallet; Ana M Ocampo de Los Ríos; Patricia Sierra Viana; Faiver Ramirez Brinez; Carlos Restrepo Castro; Gustavo Roncancio Villamil; Helena Del Corral Londoño; J Natalia Jiménez Journal: BMC Infect Dis Date: 2019-10-07 Impact factor: 3.090
Authors: Kenneth Ssekatawa; Denis K Byarugaba; Jesca L Nakavuma; Charles D Kato; Francis Ejobi; Robert Tweyongyere; Wampande M Eddie Journal: Antimicrob Resist Infect Control Date: 2021-03-18 Impact factor: 4.887